Reading Room

FHI's Quarterly Health Bulletin Network

User, Partner Attitudes Influence Barrier Use

Scientists examine how and why couples use barrier methods, and what they like or do not like about them.

Network: 2000, Vol. 20, No. 2

NetworkCopyright Family Health International, 1999. 
Network is reprinted with permission from Family Health International.

At a time when AIDS has become a devastating public health problem, the role of female barrier methods to prevent sexually transmitted diseases (STDs) has taken on new importance. To give women more options in pregnancy and STD prevention, researchers are developing new types of female barrier methods while refining existing methods.

In spite of the dual-role advantage female barrier methods provide, offering both contraception as well as protection against some STDs, use of female barrier methods remains low in many countries. The reason: Barrier method use is not practical for many women.

For some women, barrier methods are messy, inconvenient, uncomfortable and costly. For others, barrier method use is complicated by cultural norms that discourage couples from talking about sexual matters, including contraception. And for many women, successful use of female barrier methods frequently depends upon the cooperation of their male partners.

Male latex condoms offer the best protection against STDs, including HIV, and are more effective contraceptives than other barrier methods. Many couples, however, do not use condoms, believing they reduce sexual pleasure or that condoms are used only with casual partners or prostitutes.

Because of their economic dependence on men, women often find themselves unable to suggest condoms or refuse sex if condoms are not used. In Haiti, for example, researchers from the Institut Haïtien de l'Enfance and FHI found women refer to their sexual organs as mammanlajan-m or "my capital" and negotiate sex to promote their economic welfare. Yet, while women typically negotiate sex, they rarely negotiate protection. Asking a man to use condoms was viewed as a sign of infidelity, and refusal to have sex could provoke anger or violence. Both women and men agreed that if a woman refused sex, she jeopardized her own health and that of her partner. According to one man, "If I tell the woman that I feel like making love, and she does not agree, well! I will go out! Then who is responsible that I get AIDS? She is."1

In Thailand, a government program to promote male condom use in brothels has been very successful. However, condom use within marriage remains low. Although 74 percent of Thai couples use contraception, only 2 percent use condoms.2 In focus group discussions and in-depth interviews, couples said they viewed condoms as a means to prevent disease among men who engage in premarital and extramarital visits to prostitutes. Condoms were used within marriage only as a temporary or backup contraceptive. To suggest condom use for any other reason would arouse suspicions of infidelity or would be demeaning. One woman explained, "He said it would seem like I am not his wife."3

Scientists are examining these and many other human behavioral factors that affect barrier method use — how and why women use barrier methods, what they like or do not like about these devices, how partner attitudes are likely to influence use, and the gap between acceptability and use.

Female condom appeal

Women like the female condom because it can be woman-initiated and many report increased sexual pleasure for both the woman and man compared with the male condom. For these and other reasons, some users prefer it to the male condom.

In Zimbabwe, where the female condom is relatively new, users said they were pleased with the method, according to research conducted by Population Services International. "If your partner refuses to use the male condom, you just insert yours quietly," one woman told researchers. Men also approved of the method, saying it enhanced their sexual pleasure. "It allows me to be aroused more quickly," one man said.

A study of commercial sex workers in Costa Rica, conducted by the Instituto Latinoamericano de Prevención y Educación en Salud with support from FHI, found that approximately two-thirds of the 50 women interviewed preferred the female condom to the male condom.4 Women who initially reported difficulty with insertion, discomfort, or problems with the penis entering incorrectly — between the device and the vagina — said those problems diminished over time. Women reported that their partners were less likely to refuse female condom use than male condom use.

In Thailand, a study among 56 sex workers in Songkla province found that a majority of women were satisfied with the female condom and 80 percent said they were willing to use it in the future. However, 98 percent said they would prefer to use the male condom, believing the client would refuse to use the female condom, that it would not be effective and that it would be uncomfortable.5

A study in Kenya, conducted by the University of Nairobi and FHI, found that three-fourths of the women said they liked the female condom very much, and 39 percent said they preferred it to the male condom. Women said the device was comfortable, made sex more pleasurable, offered STD protection and was under their control. However, other women (24 percent) said they would not use the device in the future. Many said their partners would object.6

An FHI study in São Paulo, Brazil, and Nairobi, Kenya, also found that some women prefer the female condom over the male condom. Forty-two percent of the 103 women interviewed in Brazil said they preferred the female condom, and 21 percent said they liked it as much as the male condom.

Men said they were glad that it did not interfere with their sexual pleasure, relieved that the burden of STD protection was not theirs alone and less concerned that the female condom would tear or dislodge.7

As this research indicates, partner approval is critical for successful use of the female condom and other female barrier methods.

Diaphragm and spermicides

A study in Colombia, Turkey and the Philippines found that among 550 diaphragm users, some women liked this method because it was free from side effects, while others said it gave them more control over their contraceptive use. "I like it because I can manipulate it," said one woman. "I do not need to ask my husband. I am responsible." They also were more likely to have used a contraceptive method previously and were more likely to be dissatisfied with intrauterine devices (IUDs) or hormonal methods, such as oral contraceptives and injectables.

However, partner attitude was important. While continuation rates were comparable to those of IUDs and hormonal contraceptives, women who reported their partners were unaware of method use or who liked the method were almost three times more likely to continue than other women.8

Convenience and ease of use are important factors. In São Paulo, Brazil, 11 percent of 1,723 low-income women selected the diaphragm as their contraceptive method. However, 46 percent of diaphragm users discontinued the method within three months, compared with 29 percent of male condom users and 16 percent of oral contraceptive users.

The most common reasons women gave for initially choosing the diaphragm were concerns for health (35 percent), ease of use (16.3 percent), efficacy (15.2 percent), and woman-control (5 percent). Among women's reasons for discontinuation were that they no longer need contraception (15.2 percent), they had difficulty in handling the diaphragm (15.2 percent), they suffered side effects such as urinary tract infections (11.6 percent), the method was uncomfortable (10.7 percent), and their partner complained (10.7 percent). Researchers recommended that providers receive additional training to help new barrier method users adapt to their method and resolve any problems.9

Spermicides can be used in conjunction with a diaphragm or alone. These female-initiated methods come in a variety of formulations, including foam, vaginal suppository, gel or cream, and film. An FHI study in the Dominican Republic, Mexico and Kenya found that women did not prefer foaming contraceptive tablets to contraceptive film, believing tablets to be too wet or messy. While women did like contraceptive film, citing ease of use and lack of side effects, Latin American women complained film stuck to the fingers during insertion.10

New methods

In designing new methods for pregnancy or disease prevention, researchers are taking a closer look at what women want.

In Brazil, a study conducted by the Universidade Estadual de Campinas and the Program for the Topical Prevention of Conception and Disease found that women's ideal new contraceptive would be a gel or cream rather than a film, with no taste, color or odor. More than 600 adolescent and older adult women also said they wanted a barrier method they could insert with a pre-filled single-dose applicator. They said the method should not be messy, should be easy to store, and should last for eight hours or longer so that reapplication for other sexual acts would not be necessary. And women wanted one method that would perform two functions — disease and pregnancy prevention.

However, older adult women said they would be willing to use a new barrier method in conjunction with another contraceptive, even if the barrier method were messy, as long as it protected them from STDs, including HIV. Adolescents said they would not tolerate messiness. All women said they would not accept a method that caused vaginal burning, irritation or swelling.11

The Program for Appropriate Technology in Health (PATH) has solicited women's opinions in designing a new type of barrier method, the SILCS intravaginal barrier contraceptive. Made of silicone, the device resembles a diaphragm.

PATH interviewed diaphragm users in the United States about their likes and dislikes in using barrier methods, then recruited consumers and family planning providers to test prototypes of a new device. PATH learned that women wanted a barrier method that is less messy than those currently available, that is not inserted immediately before intercourse and that will not cause urinary tract infections, a side effect among some diaphragm users. Providers had a slightly different perspective, believing women would place a high priority on a device that was easy to insert, that was effective and that was comfortable during sex.

With comments from these groups, PATH developed the SILCS device. In a small acceptability study, 18 couples in the United States said they liked the device and found it comfortable, easy to insert and easy to remove. The SILCS device is undergoing clinical trials to evaluate barrier properties.

PATH also has conducted research on prototype devices similar to the female condom. "We are not asking 'Is this acceptable?' but 'How can it be improved?'" says Maggie Kilbourne-Brook, PATH program associate. "What we are hearing is that couples want skin-to-skin contact. If something we introduce is going to take that away, then we can try to develop a device that is minimally intrusive or if we take something away, maybe we can offer something back in return."

In its work to develop new products called microbicides, the Population Council invited women's health advocates to advise researchers on many aspects of product development, including characteristics that will make a new method acceptable. Women's groups have emphasized the urgent need for a method that is highly effective and free from side effects, says Elizabeth McGrory, a program associate with the Population Council. The ideal microbicide would be female-controlled and convenient.

Women also want a microbicide that is not messy (although the importance of this factor varies from country to country), that could be inserted well in advance of intercourse, and that does not stain clothing. While some women want a method that can be used secretly, others say they want their partner to know and to be involved.

In working with the Population Council to develop a microbicide, the Women's Health Advocates on Microbicides (WHAM) suggested that researchers explore multiple formulations to meet women's diverse needs — microbicides in gels, films, foams or sponges; microbicides with or without applicators; microbicides with and without contraceptive effects; and microbicides with or without a prescription. WHAM members said that a desirable microbicide would be one that was effective, not messy and could be inserted several hours before sex.12

If an effective microbicide were developed, its introduction would require more than providing information about the new product itself. Women and men would need education about method use, support to encourage method use, and skills in how to negotiate with partners.

"In the long run, reducing women's vulnerability will require more than a new technology," says a report by women's advocates and the Population Council. "Ultimately, empowering women to have control over their sexual lives requires a fundamental change in male-female relations and a concerted effort to eliminate the inequities that leave women economically and socially dependent on men."13

— Barbara Barnett

References

  1. Ulin PR, Cayemittes M, Gringle R. Bargaining for life: women and the AIDS epidemic in Haiti. In Long LD, Ankrah ME, eds. Women's Experiences with HIV/AIDS. (New York: Columbia University Press, 1997)91-111.
  2. World Contraceptive Use 1998, poster. New York: United Nations Department of Economic and Social Affairs, 1999.
  3. Knodel J, Pramualratana A. Prospects for increased condom use within marriage in Thailand. Int Fam Plann Perspect 1996;22(3):97-102.
  4. Madrigal J, Schifter J, Feldblum PJ. Female condom acceptability. AIDS Educ Prev 1998;10(2):105-13.
  5. Sinpisut P, Chandeying V, Skov S, et al. Perceptions and acceptability of the female condom (Femidom) amongst commercial sex workers in Songkla province, Thailand. Int J STD AIDS 1998;9(3):168-72.
  6. Ruminjo JK, Steiner M, Joanis C, et al. Preliminary comparison of the polyurethane female condom with the male condom in Kenya. East Afr Med J 1996;73(2):101-06.
  7. Ankrah EM, Attika SA. Adopting the Female Condom in Kenya and Brazil: Perspectives of Women and Men. A Synthesis. Arlington, VA: Family Health International, 1997.
  8. Brady M, Díaz J, Bulut N, et al. Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in three developing countries. Unpublished paper. The Population Council, World Health Organization, and Family Health International, 1999.
  9. Di Giacomo de Logo T, Barbosa M, Klackmann S, et al. Acceptability of the diaphragm among low-income women in São Paulo, Brazil. Int Fam Plann Perspect 1995;21(3):114-18.
  10. Steiner M, Spruyt A, Joanis C, et al. Acceptability of spermicidal film and foaming tablets among women in three countries. Int Fam Plann Perspect 1995;21(3):104-7.
  11. Hardy E, de Pádua KS, Jiménez AL, et al. Women's preferences for vaginal antimicrobial contraceptives II, preferred characteristics according to women's age and socioeconomic status. Contraception 1998;58(4):239-44; Hardy E, de Pádua KS, Jiménez AL, et al. Women's preferences for vaginal antimicrobial contraceptives III, choice of a formulation, applicator and packaging. Contraception 1998;58(4):245-49; Hardy E, de Pádua KS, Osis MJD, et al. Women's preferences for vaginal antimicrobial contraceptives IV, attributes of a formulation that would protect from STD/AIDS. Contraception 1998;58(4):251-55.
  12. Heise LL, McGrory CE, Wood SY. Practical and Ethical Dilemmas in the Clinical Testing of Microbicides, a Report on a Symposium. New York: International Women's Health Coalition, 1998.
  13. Heise.

 Promoting Partner Communication

In many cultures, men and women do not typically discuss sexual issues. If they do, the man initiates discussion and the use of family planning begins after several births, when the desired family size has been achieved.

For many women, introduction of the female condom has given them a chance to communicate with their partner about sex, pregnancy, sexually transmitted diseases (STDs) and family size.

Women in Costa Rica, Indonesia, Mexico and Senegal said the female condom gave them an opportunity to talk with their partners about safer sex.1 Some women in a U.S. study said they initiated discussions about contraception and STD protection by leaving the female condom in a place for their partner to see.2

In Kenya, where men typically are responsible for sexual decision-making and women are responsible for contraception, women said female condom use enabled them to talk with their partners about a broad range of topics, including intimacy and sexual pleasure. In Brazil, women said they felt female condom use gave them some control over their bodies and their sexuality, as well as knowledge about reproductive anatomy. "Ultimately, the women valued the fact that the female condom encouraged dialogue with their partners that went beyond sex to other issues," wrote the authors of a summary report.3

In Zimbabwe, Population Services International (PSI) has conducted a nationwide marketing campaign of a female condom under the brand name "care." Through this effort, PSI is also emphasizing the need for couples to talk with each other about sex. In order to reach couples with established relationships, where better communication is more likely to occur, PSI promotes the condom as a "contraceptive sheath" offering dual protection from both pregnancy and sexually transmitted diseases, including HIV.

PSI advertisements show a man and woman smiling and talking, with the message "for women & men who care." The emphasis is on joint decision-making about reproductive health.

"You can design an intervention that helps women negotiate condom use, but unless you address what goes on beyond the closed door, between those two people, programs will have limited impact," says Josselyn Neukom, program analyst for PSI. "The challenge is reaching the couple."

PSI campaigns are directed at both women and men because both are involved in the decision to use the female condom. "With the female condom, the man knows the woman is using it, and may have played some role in the decision to use it — he may even have introduced it. To say it is an exclusively female-controlled method is misleading," says Neukom. "PSI programs promote products, but also promote a behavior — two people talking together about prevention. And we are promoting condom use as a joint decision."

But couple communication is not the only type of interaction needed to make female condom use successful. PSI also encourages potential users to talk with health providers.

"One of the things we knew from the outset is that this product requires different strategies. Unlike the male condom, it is not something you put on the shelf, you advertise with a few billboards, and sales pick up," says Neukom. "Having confidence in one's ability to negotiate and use this product correctly are important issues. Clients need face-to-face interaction with a provider or someone else they trust, such as a peer educator or outreach worker, for information and counseling about how to use this method."

— Barbara Barnett

References

  1. More Evidence on Female Condom: Increased Protection against Sexually Transmitted Diseases, Including HIV/AIDS, press release. Geneva: Joint United Nations Programme on HIV/AIDS, 15 July 1997.
  2. El-Bassel N, Krishnan SP, Schilling RF, et al. Acceptability of the female condom among STD clinic patients. AIDS Educ Prev 1998;10(5):465-80.
  3. Ankrah EM, Attika SA. Adopting the Female Condom in Kenya and Brazil: Perspectives of Women and Men. A Synthesis. Arlington, VA: Family Health International, 1997.

For more information, visit Family Health International's Website at www.fhi.org

Go to FHI's Network


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website